Previous Close | 2.2000 |
Open | 2.1500 |
Bid | 2.0600 x 100 |
Ask | 2.1900 x 100 |
Day's Range | 2.0400 - 2.2400 |
52 Week Range | 1.5500 - 5.4100 |
Volume | |
Avg. Volume | 87,024 |
Market Cap | 20.528M |
Beta (5Y Monthly) | 0.76 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...